BioPalette
Genome Editing x Microbiome
Kobe, Japan · Founded 2017
- Headquarters
- Kobe
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- biopalette.co.jp
- Last Round
- Series ASep 2020
- Rounds
- 2
About
BioPalette is a Kobe University spinout that develops genome-edited bacteria as living medicines for microbiome-based therapeutics. Its proprietary non-cutting CRISPR base-editing technologies (Target-AID and Target-G) enable precise modification of gut microbiomes without DNA strand breaks, targeting diseases driven by microbiome dysbiosis.
Summary
BioPalette is a Biotech company based in Kobe, Japan, founded in 2017. Its most recent funding was a Series A round in Sep 2020. Investors include Jafco Ventures, UTEC - The University and Eight Roads Ventures.
Funding History
Sep 2020
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/biopalette"><img src="https://indexed.vc/api/badge/company/biopalette" alt="BioPalette on Indexed.vc" width="260" height="76" /></a>